{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:20:41Z","timestamp":1789399241725,"version":"build-2803163510"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Rectal cancer is an increasingly prevalent malignancy, with growing interest in organ preservation strategies as an alternative to radical surgery, particularly for tumors of the mid-lower rectum. Radiotherapy plays a central role in these approaches and contact X-ray brachytherapy (CXB or Papillon technique) allows for safe dose escalation directly to the tumor, enhancing local control while minimizing toxicity. This report describes the development and implementation of a refined protocol for Papillon CXB, addressing technical challenges related to patient comfort, applicator placement, and procedural accuracy. By the end of 2024, a total of 129 patients with mid-lower rectal cancer had been treated with Papillon CXB in Swiss centers. In February 2022, a refined protocol was introduced, incorporating procedural sedation (Propofol), the lateral decubitus position, and close collaboration with gastroenterologists to improve tumor visualization and precise applicator placement. This updated approach has been applied to 73 patients, mainly with curative intent and organ preservation goals. Sedation significantly improved patient comfort and reduced movement during applicator insertion. The applicator demonstrated excellent stability, even in anatomically challenging cases. The procedure proved to be straightforward, smoothly integrated into clinical workflows, and well-tolerated by patients, with high satisfaction reported by both patients and the medical team. This Swiss protocol offers a practical and patient-centered refinement of Papillon CXB. By addressing critical technical and clinical challenges, it enhances procedural feasibility and safety, ultimately supporting optimal oncological outcomes and wider adoption in rectal cancer management.<\/jats:p>","DOI":"10.3389\/fonc.2025.1608427","type":"journal-article","created":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T11:51:59Z","timestamp":1752061919000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Organ preservation in rectal cancer with contact x-ray brachytherapy (Papillon): a refined Swiss protocol to improve real-world feasibility"],"prefix":"10.3389","volume":"15","author":[{"given":"Cristina","family":"Picardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Caparrotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Brunner-Schaub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Christen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Fargier-Voiron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Drepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Von Laufen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Montemurro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Ris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Matzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v28.i12.1234","article-title":"Surgical management of rectal cancer in elderly patients: A review","volume":"28","author":"Papaccio","year":"2022","journal-title":"World J Gastroenterol"},{"key":"B4","unstructured":"Colorectal cancer statistics 2020. Press release\n          \n          \n          2020"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-18-1111","article-title":"Global increasing incidence of young-onset colorectal cancer across 5 continents: A joinpoint regression analysis of 1,922,167 cases","volume":"28","author":"Lui","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.12771\/emj.2022.e12","article-title":"Low anterior resection syndrome: Pathophysiology, risk factors, and current management","volume":"45","author":"Yeo","year":"2022","journal-title":"Ewha Med J"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000141194.27992.32","article-title":"Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: Long-term results","volume":"240","author":"Habr-Gama","year":"2004","journal-title":"Ann Surg"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31078-X","article-title":"Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): An international multicenter registry study","volume":"391","author":"Van der Valk","year":"2018","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00032","article-title":"Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy","volume":"40","author":"Garcia-Aguilar","year":"2022","journal-title":"J Clin Oncol"},{"key":"B10","article-title":"Adjuvant radiotherapy for rectal cancer: A systematic overview of 8507 patients from 22 randomized trials","volume":"358","author":"Gray","year":"2001","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(03)01020-9","article-title":"Radiotherapy alone in the curative treatment of rectal carcinoma","volume":"4","author":"Gerard","year":"2003","journal-title":"Lancet Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ijrobp.2012.05.017","article-title":"Radiation dose-response model for locally advanced rectal cancer after preoperative chemoradiation therapy","volume":"85","author":"Appelt","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.12.002","article-title":"Correlation in rectal cancer between clinical tumor response after neoadjuvant radiotherapy and sphincter or organ preservation: 10-year results of the Lyon R 96\u201302 randomized trial","volume":"83","author":"Ortholan","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.11.007","article-title":"Organ or sphincter preservation for rectal cancer: The role of contact X-ray brachytherapy in a monocentric series of 112 patients","volume":"72","author":"Frin","year":"2017","journal-title":"Eur J Cancer"},{"key":"B15","article-title":"Dose escalation using contact X-ray brachytherapy after external beam radiotherapy as non-surgical treatment option for rectal cancer: Outcomes from a single-center experience","volume":"100","author":"Myint","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.radonc.2021.07.021","article-title":"A multi-center analysis of adjuvant contact X-ray brachytherapy (CXB) in rectal cancer patients treated with local excision\u2014Preliminary results of the CONTEM 1 study","volume":"162","author":"Dhadda","year":"2021","journal-title":"Radiother Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16132318","article-title":"High rates of organ preservation in rectal cancer with Papillon contact X-ray radiotherapy: Results from a Swiss cohort","volume":"16","author":"Picardi","year":"2024","journal-title":"Cancers"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00392-2","article-title":"Neoadjuvant chemoradiotherapy with radiation dose escalation with contact X-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3 rectal adenocarcinoma (OPERA): A phase 3, randomized controlled trial","volume":"8","author":"Gerard","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B19","article-title":"A phase III randomized trial on the addition of a contact X-ray brachytherapy boost to standard neoadjuvant chemo-radiotherapy for organ preservation in early rectal adenocarcinoma: 5 year results of the OPERA trial","volume":"26","author":"Baron","year":"2025","journal-title":"Lancet Oncol"},{"key":"B20","volume-title":"Phase 3 Evaluation of Contact X-ray Brachytherapy for Rectal Preservation in Intermediate Low or Mid Rectal Adenocarcinoma (TRESOR) (NCT06402864)","year":"2023"},{"key":"B21","first-page":"100646","article-title":"FOLFIRINOX chemotherapy combined with contact X-ray brachytherapy 50 kVp and CAP50 chemoradiotherapy aiming at organ preservation for selected intermediate distal-middle cT2\u2013T3 rectal cancers: A feasibility study","volume":"42","author":"Sun Myint","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"B22","volume-title":"Risk Communication Format: Radical Surgery - Age 75 to 84, T1 and T2 Rectal Cancer [Infographic]","author":"Paling","year":"2000"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1608427\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T11:52:01Z","timestamp":1752061921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1608427\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":22,"alternative-id":["10.3389\/fonc.2025.1608427"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1608427","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"article-number":"1608427"}}